Find a Tender
complete
Official procurement procedure
(NU/1433-47) Kargenera: The Provision of Business Consultancy to Assist Commercialisation of University Research
Business and management consultancy and related services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Newcastle University: "(NU/1433-47) Kargenera: The Provision of Business Consultancy to Assist Commercialisation of University Research". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Newcastle University | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Newcastle University
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Newcastle University. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
2.4Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 104 active published awards; 98 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNewcastle University | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSDynamic market | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Feb 2023, 14:13 GMT | Last source update6 Feb 2023, 14:13 GMT | Recurring procurementNot published |
ClassificationBusiness and management consultancy and related services | ||
Delivery area | ||
OCIDocds-h6vhtk-03a331 | ||
What is being bought
The University of Southampton have developed a unique DNA based therapeutic to activate NK cells against cancer. The therapeutic is delivered intramuscularly in combination with DNA encoding the potent immune stimulating cytokine IL-15.
The objective is for an Executive to jointly work with the team to bring the opportunity towards and ultimately achieve launch of a new spinout company.
What changed
From the official release history
- Status changed to complete
6 Feb 2023, 14:13 GMT - Official notice release published
6 Feb 2023, 14:13 GMT - Buyer information updated
6 Feb 2023, 14:13 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe project description is included below: Phase 1 Opportunity Validation and Business Plan Creation - Executive leads all activity; ensures other team members support on relevant technical/ application needs inputs; if requested by Exec, UoS R&IS department will assist defining business plan requirements Phase 2 Research organisation Approval In Principle to Spinout - Executive briefed by UoS R&IS on relevant documentation, and assisted by that team to complete this and submit to first available regular bi-monthly Southampton Enterprise Board meetings; Attendance of networking conferences to accelerate commercialisation process. Phase 3 Achieve “Ready to Spin” status Phase 4 Investor willingness to complete necessary funding round;Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
6 Feb 2023, 14:13 GMT - Award active
Not published · Not published - Contract active
Signed 11 Jan 2023, 00:00 GMT · £30,000
Commercial outcome and competition
Awards Lifescience Advisors Limited Not published · Not published · active |
Contracts Contract £30,000 · signed 11 Jan 2023, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 1 (lot 1) |
Buyer and organisations in this procedure
Newcastle University
Contracting authority GB-FTS-168Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |